255 related articles for article (PubMed ID: 28780736)
1. Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.
Crum-Cianflone NF; Sullivan E
Infect Dis Ther; 2017 Sep; 6(3):333-361. PubMed ID: 28780736
[TBL] [Abstract][Full Text] [Related]
2. Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.
Crum-Cianflone NF; Sullivan E
Infect Dis Ther; 2017 Sep; 6(3):303-331. PubMed ID: 28779442
[TBL] [Abstract][Full Text] [Related]
3. Measles Seroprevalence and Vaccine Responses in Human Immunodeficiency Virus-infected Adolescents and Adults: A Systematic Review.
Loevinsohn G; Rosman L; Moss WJ
Clin Infect Dis; 2019 Aug; 69(5):836-844. PubMed ID: 30452621
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.
Baden LR; Stieh DJ; Sarnecki M; Walsh SR; Tomaras GD; Kublin JG; McElrath MJ; Alter G; Ferrari G; Montefiori D; Mann P; Nijs S; Callewaert K; Goepfert P; Edupuganti S; Karita E; Langedijk JP; Wegmann F; Corey L; Pau MG; Barouch DH; Schuitemaker H; Tomaka F;
Lancet HIV; 2020 Oct; 7(10):e688-e698. PubMed ID: 33010242
[TBL] [Abstract][Full Text] [Related]
5. [Vaccinations of HIV-infected travelers].
Couzigou C; Voyer C; Shaghaghi CK; Bourée P; Vittecoq D
Med Mal Infect; 2009 Jan; 39(1):21-8. PubMed ID: 18723304
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
Barry H; Mutua G; Kibuuka H; Anywaine Z; Sirima SB; Meda N; Anzala O; Eholie S; Bétard C; Richert L; Lacabaratz C; McElrath MJ; De Rosa S; Cohen KW; Shukarev G; Robinson C; Gaddah A; Heerwegh D; Bockstal V; Luhn K; Leyssen M; Douoguih M; Thiébaut R;
PLoS Med; 2021 Oct; 18(10):e1003813. PubMed ID: 34714820
[TBL] [Abstract][Full Text] [Related]
7. Vaccination in HIV-infected adults.
Crum-Cianflone NF; Wallace MR
AIDS Patient Care STDS; 2014 Aug; 28(8):397-410. PubMed ID: 25029589
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of HIV-infected pregnant women: implications for protection of their young infants.
Dangor Z; Nunes MC; Kwatra G; Lala SG; Madhi SA
Trop Dis Travel Med Vaccines; 2017; 3():1. PubMed ID: 28883971
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and routine childhood immunization: a review.
Clements CJ; von Reyn CF; Mann JM
Bull World Health Organ; 1987; 65(6):905-11. PubMed ID: 3325188
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.
Pollard AJ; Launay O; Lelievre JD; Lacabaratz C; Grande S; Goldstein N; Robinson C; Gaddah A; Bockstal V; Wiedemann A; Leyssen M; Luhn K; Richert L; Bétard C; Gibani MM; Clutterbuck EA; Snape MD; Levy Y; Douoguih M; Thiebaut R;
Lancet Infect Dis; 2021 Apr; 21(4):493-506. PubMed ID: 33217361
[TBL] [Abstract][Full Text] [Related]
12. Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation.
Bamford A; Manno EC; Mellado MJ; Spoulou V; Marques L; Scherpbier HJ; Niehues T; Oldakowska A; Rossi P; Palma P;
Vaccine; 2016 Nov; 34(46):5587-5594. PubMed ID: 27727030
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
[TBL] [Abstract][Full Text] [Related]
14. Allergic reactions to Japanese encephalitis vaccine.
Plesner AM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
[TBL] [Abstract][Full Text] [Related]
15. Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model.
Dzhivhuho GA; Rehrl SA; Ndlovu H; Horsnell WGC; Brombacher F; Williamson AL; Chege GK
PLoS Pathog; 2018 Jul; 14(7):e1007182. PubMed ID: 30048550
[TBL] [Abstract][Full Text] [Related]
16. Vaccination in the Adult Patient Infected with HIV: A Review of Vaccine Efficacy and Immunogenicity.
El Chaer F; El Sahly HM
Am J Med; 2019 Apr; 132(4):437-446. PubMed ID: 30611828
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.
Lee KY; Tsai MS; Kuo KC; Tsai JC; Sun HY; Cheng AC; Chang SY; Lee CH; Hung CC
Hum Vaccin Immunother; 2014; 10(12):3700-10. PubMed ID: 25483681
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study.
Berkowitz EM; Moyle G; Stellbrink HJ; Schürmann D; Kegg S; Stoll M; El Idrissi M; Oostvogels L; Heineman TC;
J Infect Dis; 2015 Apr; 211(8):1279-87. PubMed ID: 25371534
[TBL] [Abstract][Full Text] [Related]
19. High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
Kitchen M; Leierer G; Kistner O; Wodal W; Gisinger M; Zangerle R; Sarcletti M
Vaccine; 2022 Jun; 40(29):3948-3953. PubMed ID: 35606234
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
